Open access
Open access
Powered by Google Translator Translator

Archives

Comparison Approaches to Lipid Management: AHA/ACC vs. ESC/EAS Guidelines

12 May, 2020 | 03:07h | UTC

Comparison of Transatlantic Approaches to Lipid Management: The AHA/ACC/Multisociety Guidelines vs the ESC/EAS Guidelines – Mayo Clinic Proceedings

 


Tue May 12 – 10 Stories of The Day!

12 May, 2020 | 03:41h | UTC

 

1 – Association of Treatment with Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State – JAMA

Related: Large Observational Study Finds Hydroxychloroquine Provides no Benefit in Hospitalized Patients with Covid-19

 

2 – Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units – JAMA Pediatrics

Commentaries: A study of 48 children in intensive care with the coronavirus found 18 needed ventilators. Most had underlying conditions – Business Insider AND Study Offers Details of U.S. Children Severely Sickened by Coronavirus – The New York Times

 

3 – Considerations for public health and social measures in the workplace in the context of COVID-19 – World Health Organization

 

4 – The cost of inaction: COVID-19-related service disruptions could cause hundreds of thousands of extra deaths from HIV – World Health Organization

Original Preprints: Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models AND Estimation of the potential effects of disruption to HIV programs in sub-Saharan Africa caused by COVID-19: results from multiple models APPENDIX

 

5 – AIDS, TB And Malaria Set To Get Deadlier Due To Coronavirus – Forbes

Related: AIDS, TB And Malaria: Coronavirus Threatens The Endgame – Forbes AND The Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low- and Middle-Income Countries – Imperial College London AND The potential impact of health service disruptions on the burden of malaria: a modelling analysis for countries in sub-Saharan Africa – World Health Organization AND The Potential Impact Of The Covid-19 Response On Tuberculosis In High-Burden Countries: A Modelling Analysis

 

6 – Abdominal Imaging Findings in COVID-19: Preliminary Observations – Radiology

News Release: Imaging reveals bowel abnormalities in patients with COVID-19 – Radiological Society of North America

 

7 – Real-time tracking of self-reported symptoms to predict potential COVID-19 – Nature Medicine

Commentaries: New AI diagnostic can predict COVID-19 without testing – King’s College London AND Expert reaction to study looking at possibility of using real-time tracking of self-reported symptoms to predict potential COVID-19 without testing – Science Media Centre AND Coronavirus: research reveals way to predict infection – without a test – The Conversation AND Loss of smell and taste may actually be one of the clearest signs of COVID-19 – Science News

 

8 – Ethics and governance for digital disease surveillance – Science

 

9 – Richard Lehman’s Covid-19 Reviews, 11 May 2020 – The BMJ Opinion

In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19

 

10 – Coronavirus Disease (COVID-19) Updates / 12 May 2020 Edition

12 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Triple Therapy Antiviral Combination Seems Promising for COVID-19 in Open-label, Randomized, Phase 2 Trial

11 May, 2020 | 00:42h | UTC

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial – The Lancet

Commentaries: Interferon beta-1b for COVID-19 – The Lancet AND New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial – The Lancet AND A Drug Cocktail Hastens Recovery in Some Coronavirus Patients – The New York Times AND Triple drug therapy helps coronavirus patients recover more quickly, study finds – CNN AND Triple antiviral drug shows early promise in COVID-19 trial – Reuters AND Expert reaction to a study about a phase 2 trial of a triple antiviral drug combination treatment for COVID-19 – Science Media Centre

 


Preliminary Study Evaluates Interleukin-1 Blockade for Patients with Severe Covid-19

11 May, 2020 | 00:34h | UTC

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study – The Lancet Rheumatology

Commentaries: Expert reaction to study looking at use of arthritis drug anakinra in hospitalised patients with severe COVID-19 – Science Media Centre AND Small study of patients with severe COVID-19 treated with the arthritis drug anakinra finds clinical improvements – The Lancet

 


Perspective: Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician

11 May, 2020 | 00:37h | UTC

Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician – Circulation (PDF)

 


Perspective: “Do Not Stay at Home: We Are Ready for You”

11 May, 2020 | 00:40h | UTC

Do Not Stay at Home: We Are Ready for You – NEJM Catalyst

“We must never lose sight of all the other patients who need our care today. Patients with any symptom indicating an emergency or severe disease must NOT stay at home.”

 


Guidance Statement: Mechanical Thrombectomy in the Era of the COVID-19 Pandemic

11 May, 2020 | 00:32h | UTC

Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology – Stroke

Commentaries: Guidance for Treating Stroke Patients During COVD-19 Crisis Developed – Boston University School of Medicine AND Mechanical Thrombectomy and Emergency Preparedness Guidance in COVID-19 Era – American College of Cardiology

 


Sharp Drop in Stroke Evaluations During COVID-19 Pandemic

11 May, 2020 | 00:35h | UTC

Collateral Effect of Covid-19 on Stroke Evaluation in the United States – New England Journal of Medicine

Commentary: Stroke evaluations drop by nearly 40% during COVID-19 pandemic – Washington University School of Medicine

 


COVID-19 Research in Brief: 2 May to 8 May, 2020

11 May, 2020 | 00:24h | UTC

COVID-19 Research in Brief: 2 May to 8 May, 2020 – Nature Medicine

 


Canadian Study Finds Temperature, Latitude Not Associated with COVID-19 Spread

11 May, 2020 | 00:30h | UTC

Impact of climate and public health interventions on the COVID-19 pandemic: A prospective cohort study – Canadian Medical Association Journal

News Release: Canadian study finds temperature, latitude not associated with COVID-19 spread – Canadian Medical Association Journal

 


[Abstract Only] Study: No Increased Risk of Infections with Resterilized and Reused Pacemakers or Defibrillators

11 May, 2020 | 00:21h | UTC

Infections Associated with Resterilized Pacemakers and Defibrillators – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Infections With Resterilized Pacemakers and Defibrillators – American College of Cardiology AND No increased risk of infection with recycled pacemakers and defibrillators – Cardiovascular Business

 


Revisited: Therapeutic and Toxic Blood Concentrations of More than 1100 drugs and Other Xenobiotics

11 May, 2020 | 00:15h | UTC

Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics – Critical Care

 


Perspective: When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?

11 May, 2020 | 00:23h | UTC

When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials? – JAMA (via @AndersPerner)

Author Interview: When Should Physicians Act on Non–Statistically Significant Results From Clinical Trials?

“The burden of proof required to do “more” should probably be higher than to do “less,” particularly if doing “more” is likely to increase overall health care costs.”

 


The Emerging Long-term Complications of Covid-19, Explained

11 May, 2020 | 00:27h | UTC

The emerging long-term complications of Covid-19, explained – Vox

Related: Coronavirus: Sickest patients face long recovery – BBC AND Surviving Covid-19 May Not Feel Like Recovery for Some – New England Journal of Medicine

 


Canadian Guideline: Acetylsalicylic Acid for Prevention of Vascular Events

11 May, 2020 | 00:05h | UTC

Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events – Canadian Medical Association Journal

 


Meta-Analysis: Furosemide Stress Test as a Predictive Marker of Acute Kidney Injury Progression or Renal Replacement Therapy

11 May, 2020 | 00:12h | UTC

Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis – Critical Care

 


Position Paper: Antimicrobial Therapeutic Drug Monitoring in Critically Ill Adult Patients

11 May, 2020 | 00:19h | UTC

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper – Intensive Care Medicine

Commentary: New antibiotic guidelines could save more lives in intensive care units – News Medical

 


Study: Combustible vs. Electronic Cigarettes Alterations in Vascular Function

11 May, 2020 | 00:10h | UTC

Alterations in Vascular Function Associated With the Use of Combustible and Electronic Cigarettes – Journal of the American Heart Association

Commentary: Like Tobacco, Long-term E-Cigarettes Harm Vascular Function – TCTMD AND Vascular Damage Similar With E-cigarettes, Traditional Cigarettes – American College of Cardiology

 


Systematic Review: Pharmacological treatment for Buerger’s disease

10 May, 2020 | 23:58h | UTC

Pharmacological treatment for Buerger’s disease – Cochrane Library

Summary: Pharmacological treatment (drugs) for Buerger’s disease

 


NCCN Guideline: Hematopoietic Cell Transplantation

10 May, 2020 | 23:53h | UTC

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network

 


Systematic Review: Pelvic Floor Muscle Training for Preventing and Treating Urinary and Fecal Incontinence in Antenatal and Postnatal Women

11 May, 2020 | 00:02h | UTC

Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women – Cochrane Library

Summary: How effective is pelvic floor muscle training undertaken during pregnancy or after birth for preventing or treating incontinence? – Cochrane Library

 


Large Observational Study Finds Hydroxychloroquine Provides no Benefit in Hospitalized Patients with Covid-19

8 May, 2020 | 10:41h | UTC

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 – New England Journal of Medicine

Editorial: The Urgency of Care during the Covid-19 Pandemic — Learning as We Go

 


Treatment of Community-Acquired Pneumonia During the COVID-19 Pandemic

8 May, 2020 | 10:35h | UTC

Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic – Annals of Internal Medicine

 


Podcast: Studying Potential Covid-19 Therapies

8 May, 2020 | 10:38h | UTC

Audio Interview: Studying Potential Covid-19 Therapies – New England Journal of Medicine

 


Mon May 11 – 10 Stories of The Day!

11 May, 2020 | 00:44h | UTC

 

1 – Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial – The Lancet

Commentaries: Interferon beta-1b for COVID-19 – The Lancet AND New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial – The Lancet AND A Drug Cocktail Hastens Recovery in Some Coronavirus Patients – The New York Times AND Triple drug therapy helps coronavirus patients recover more quickly, study finds – CNN AND Triple antiviral drug shows early promise in COVID-19 trial – Reuters AND Expert reaction to a study about a phase 2 trial of a triple antiviral drug combination treatment for COVID-19 – Science Media Centre

 

2 – Do Not Stay at Home: We Are Ready for You – NEJM Catalyst

We must never lose sight of all the other patients who need our care today. Patients with any symptom indicating an emergency or severe disease must NOT stay at home.”

 

3 – Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician – Circulation (PDF)

 

4 – Collateral Effect of Covid-19 on Stroke Evaluation in the United States – New England Journal of Medicine

Commentary: Stroke evaluations drop by nearly 40% during COVID-19 pandemic – Washington University School of Medicine

 

5 – Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study – The Lancet Rheumatology

Commentaries: Expert reaction to study looking at use of arthritis drug anakinra in hospitalised patients with severe COVID-19 – Science Media Centre AND Small study of patients with severe COVID-19 treated with the arthritis drug anakinra finds clinical improvements – The Lancet

 

6 – Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology – Stroke

Commentaries: Guidance for Treating Stroke Patients During COVD-19 Crisis Developed – Boston University School of Medicine AND Mechanical Thrombectomy and Emergency Preparedness Guidance in COVID-19 Era – American College of Cardiology

 

7 – Impact of climate and public health interventions on the COVID-19 pandemic: A prospective cohort study – Canadian Medical Association Journal

News Release: Canadian study finds temperature, latitude not associated with COVID-19 spread – Canadian Medical Association Journal

 

8 – The emerging long-term complications of Covid-19, explained – Vox

Related: Coronavirus: Sickest patients face long recovery – BBC AND Surviving Covid-19 May Not Feel Like Recovery for Some – New England Journal of Medicine

 

9 – COVID-19 Research in Brief: 2 May to 8 May, 2020 – Nature Medicine

 

10 – Coronavirus Disease (COVID-19) Updates / 11 May 2020 Edition

11 May 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.